Smith Karen L. bought SKYE
March 31, 2026 · Form 4 insider transaction
Smith Karen L. bought 75,000 shares of Skye Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
75,000
Price
$0.00
Total value
N/A
InsiderSmith Karen L.
RoleDirector
CompanySkye Bioscience, Inc. (SKYE)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after75,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The stock option vests in equal monthly installments over the one year period beginning March 31, 2026.